Observational Study of Safety of Flu Cell Culture Derived Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Vaccine

CompletedOBSERVATIONAL
Enrollment

4,028

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

January 31, 2011

Conditions
Novel Influenza A (H1N1)A New Flu Virus of Swine Origin
Interventions
OTHER

Non-intervention observational study

Non-intervention observational study

Trial Locations (10)

1810

Clinica Indisa, Av. Santa Maria

Unknown

Fundación Universitaria de Ciencias de Salud- Hospital San José Calle, Bogotá

Nueva EPS: Centro de Especialistas Barrios Unidos - MEDERI, Calle 66 # 40-07 - Bogotá

Hospital local de Yopal E.S.E, Calle 9 No. 24-37 - Yopal, Casanare

Clinica del Country, Carrera 16 No. 82-57 Bogotá

Hospital Universitario Infantil San José, Carrera 52 No. 67a-71 - Barrios Unidos - Bogotá

CAIMED - Centro de Atencion e Investigación Medica, Cra. 42 A No. 17-50

Augustenburger Platz 1

Policlinique Médicale Universitaire, Rue Du Bugnon 44

Institute of Social and Preventive Medicine, Division of Communicable Diseases, Hirschengraben 84

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis Vaccines

INDUSTRY